Skip to main content

Advertisement

Log in

Is 70 the new 50? Complications and outcomes of transjugular intrahepatic portosystemic shunt in older versus younger patients

  • Special Section : Liver Transplantation
  • Published:
Abdominal Radiology Aims and scope Submit manuscript

Abstract

Background

An increased risk of complications of TIPS in patients older than 65 years of age has been described, but data is limited. The objective of this study was to determine if the rate of complications post-TIPS differs in patients 65 or younger, compared to those older than 65 years of age.

Methods

A retrospective chart review was performed for all patients who underwent TIPS procedure at Banner—University Medical Center Phoenix, from 2010 to 2018, specifically focusing on complications and outcomes post-TIPS. In total, 402 patients were included in this analysis. Complications included portosystemic encephalopathy, post-TIPS infection, acute kidney injury requiring hemodialysis, hemorrhage, respiratory complications, need for transplant, or death.

Results

A total of 402 patients were included and divided into two groups: 300 (74.6%) were 65 years or younger (ages 53 ± 9), and 102 were older than 65 years (70 ± 5 (p < 0.001)). There were no statistically significant differences between age groups when comparing portosystemic encephalopathy, post-TIPS infection, acute kidney injury, respiratory complications, need for transplant, or death.

Conclusion

In this large, single-center cohort, there was no statistically significant difference in the rate of complications of TIPS between the two age groups. Based on our results, TIPS procedure is an equally safe option for properly selected patients with complications of portal hypertension, regardless of age.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Colapinto RF, Stronell RD, Gildiner M, et al. Formation of intrahepatic portosystemic shunts using a balloon dilatation catheter: Preliminary clinical experience. Am J Roentgenol 1983;140:709-714.

    Article  CAS  Google Scholar 

  2. Boyer T, Haskal Z. AASLD Practice Guidelines: The Role of Transjugular Intrahepatic Portosystemic Shunt (TIPS) in the Management of Portal Hypertension. Hepatology 2010;51:1-17.

    Article  Google Scholar 

  3. Bureau C, Garcia-Pagan JC, Otal P, et. al. Improved clinical outcome using polytetrafluoroethylene-coated stents for TIPS: Results of a randomized study. Gastroenterology 2004;126:469-475.

    Article  Google Scholar 

  4. Kraglund F, Jepsen P, Amanavicius N, et al. Long-term effects and complications of the transjugular intrahepatic portosystemic shunt: a single-centre experience. Scand J Gastroentero 2019;54:899-904.

    Article  Google Scholar 

  5. Lee E, Kuei A, Saab S, et al. Nationwide trends and predictors of inpatient mortality in 83884 transjugular intrahepatic portosystemic shunt. World J Gastroenterology 2016;22:5780-5789.

    Article  Google Scholar 

  6. McCormick PA, Dick R, Burroughs AK. Review article: the transjugular intrahepatic portosystemic shunt (TIPS) in the treatment of portal hypertension. Aliment Pharmacol Ther 2007;8:273-282.

    Article  Google Scholar 

  7. Bettinger D, Knüppel E, Euringer W, et al. Efficacy and safety of transjugular intrahepatic portosystemic shunt (TIPSS) in 40 patients with hepatocellular carcinoma. Aliment Pharmacol Ther 2014;41:126-136.

    Article  Google Scholar 

  8. Casadaban LC, Parvinian A, Zivin SP, et al. MELD score for prediction of survival after emergent TIPS for acute variceal hemorrhage: derivation and validation in a 101-patient cohort. Ann Hepatol 2015;14:380-388.

    Article  CAS  Google Scholar 

  9. Ferral H, Gamboa P, Postoak D, et al: Survival after elective transjugular intrahepatic portosystemic shunt creation: Prediction with Model for End-Stage Liver Disease Score. Radiology 2004;231:231-236.

    Article  Google Scholar 

  10. Loffroy R, Favelier S, Pottecher P, et al. Transjugular intrahepatic portosystemic shunt for acute variceal gastrointestinal bleeding: Indications, techniques and outcomes. Diagnostic and Interventional Imaging 2015;96:745-755.

    Article  CAS  Google Scholar 

  11. Ronald J, Wang Q, Choi S, et al. Albumin-bilirubin grade versus MELD score for predicting survival after transjugular intrahepatic portosystemic shunt (TIPS) creation. Diagn Interv Imaging 2018;99:163-168.

    Article  CAS  Google Scholar 

  12. Schepke M, Roth F, Fimmers R, et al: Comparison of MELD, Child-Pugh, and Emory model for the prediction of survival in patients undergoing trans- jugular intrahepatic portosystemic shunting. Am J Gastroenterol 2003;98:1167-1174.

    Article  Google Scholar 

  13. Siramolpiwat S. Transjugular intrahepatic portosystemic shunts and portal hypertension-related complications. World J Gastroenterolg 2014;20:16996.

    Article  Google Scholar 

  14. Liu M, Bisht R, Koblinski J, et al. “Is 70 the New 50? Complications and Outcome of TIPS in Older Versus Younger Patients.” Poster presentation at the 2018 AASLD Liver Meeting, November 2018, San Francisco, CA.

  15. Dhanasekaran R, Gonzales P, West J, et al. Predictors of early mortality post transjugular intrahepatic portosystemic shunts and the role of hepatic venous pressure gradient. Gastrointest Interv 2012;1:63–68.

    Article  Google Scholar 

  16. Parvinian A, Shah K, Couture P, et al. Older Patient Age May Predict Early Mortality after Transjugular Intrahepatic Portosystemic Shunt Creation in Individuals at Intermediate Risk. J Vasc Interv Radiol 2013;24:941–946.

    Article  Google Scholar 

  17. Lerrigo R, Beste L, Leipertz S, et al. Characteristics and outcomes of transjugular intrahepatic portosystemic shunt recipients in the VA Healthcare System. Eur Journal of Gastroenterol Hepatol 2016;28:667–675.

    Article  Google Scholar 

  18. Suraweera D, Jimenez M, Viramontes M, et al. Age-related Morbidity and Mortality After Transjugular Intrahepatic Portosystemic Shunts. Journal of Clinical Gastroenterology. 2017;51(4):360-363.

    Article  Google Scholar 

Download references

Acknowledgements

The authors are in debt to the Interventional Radiology team at BUMCP, who performed the TIPS procedure during the years of the study: Drs. Kevin Hirsh, David Wood, Steven Chen and Cole Mendenhall.

Funding

Ester C. Little MD has a research grant on NAFLD from Intercept Pharmaceutical. Mark N. Wong MD is a speaker for AppVie Inc. for Hepatitis C and a speaker for Gilead Sciences for Hepatitis B. There are no disclosures from any other author.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ester C. Little.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bisht, R.U., Liu, M.C., Koblinski, J.E. et al. Is 70 the new 50? Complications and outcomes of transjugular intrahepatic portosystemic shunt in older versus younger patients. Abdom Radiol 46, 2789–2794 (2021). https://doi.org/10.1007/s00261-020-02533-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00261-020-02533-3

Keywords

Navigation